Showing 1 - 7 results of 7 for search 'Yuehong Kong', query time: 0.04s
Refine Results
-
1
Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Negative Patient With Refractory Metastatic Esophageal Squamous C... by Xiangrong Zhao, Xiangrong Zhao, Yuehong Kong, Yuehong Kong, Liyuan Zhang, Liyuan Zhang
Published 2020-09-01
Article -
2
Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers by Yuehong Kong, Yuehong Kong, Yuehong Kong, Yifu Ma, Yifu Ma, Yifu Ma, Xiangrong Zhao, Xiangrong Zhao, Xiangrong Zhao, Jie Pan, Zhi Xu, Liyuan Zhang, Liyuan Zhang, Liyuan Zhang
Published 2021-03-01
Article -
3
PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report by Jiabao Yang, Jiabao Yang, Jiabao Yang, Pengfei Xing, Pengfei Xing, Pengfei Xing, Yuehong Kong, Yuehong Kong, Yuehong Kong, Meiling Xu, Meiling Xu, Meiling Xu, Liyuan Zhang, Liyuan Zhang, Liyuan Zhang
Published 2023-04-01
Article -
4
PRaG Therapy of Refractory Metastatic Gastric Cancer: A Case Report by Hong Xu, Hong Xu, Zhihui Hong, Meiling Xu, Meiling Xu, Meiling Xu, Yuehong Kong, Yuehong Kong, Yuehong Kong, Yifu Ma, Yifu Ma, Yifu Ma, Chanchan Shan, Pengfei Xing, Pengfei Xing, Pengfei Xing, Liyuan Zhang, Liyuan Zhang, Liyuan Zhang
Published 2022-07-01
Article -
5
Gut Bacteria Erysipelatoclostridium and Its Related Metabolite Ptilosteroid A Could Predict Radiation-Induced Intestinal Injury by Shang Cai, Shang Cai, Shang Cai, Yongqiang Yang, Yongqiang Yang, Yongqiang Yang, Yuehong Kong, Yuehong Kong, Yuehong Kong, Qi Guo, Qi Guo, Qi Guo, Yingying Xu, Yingying Xu, Yingying Xu, Pengfei Xing, Pengfei Xing, Pengfei Xing, Yanze Sun, Yanze Sun, Yanze Sun, Jianjun Qian, Jianjun Qian, Jianjun Qian, Ruizhe Xu, Ruizhe Xu, Ruizhe Xu, Liwei Xie, Liwei Xie, Liwei Xie, Yijia Hu, Yijia Hu, Yijia Hu, Min Wang, Ming Li, Ye Tian, Ye Tian, Ye Tian, Weidong Mao, Weidong Mao, Weidong Mao
Published 2022-03-01
Article -
6
Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre s... by Yong Peng, Hong Zhang, Junjun Zhang, Liyuan Zhang, Pengfei Xing, Yuehong Kong, Rongzheng Chen, Meiling Xu, Guangqiang Chen, Zhihui Hong, Xiaoxiao Dai, Yifu Ma, Xiangrong Zhao, Chenyang Zhang
Published 2024-03-01
Article -
7
PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study by Yuehong Kong, Yuehong Kong, Yuehong Kong, Xiangrong Zhao, Xiangrong Zhao, Xiangrong Zhao, Meiling Xu, Meiling Xu, Meiling Xu, Jie Pan, Yifu Ma, Yifu Ma, Yifu Ma, Li Zou, Li Zou, Li Zou, Qiliang Peng, Qiliang Peng, Qiliang Peng, Junjun Zhang, Junjun Zhang, Junjun Zhang, Cunjin Su, Zhi Xu, Wei Zhou, Wei Zhou, Wei Zhou, Yong Peng, Yong Peng, Yong Peng, Jiabao Yang, Jiabao Yang, Jiabao Yang, Chengliang Zhou, Chengliang Zhou, Chengliang Zhou, Yujia Li, Yujia Li, Yujia Li, Qiuchen Guo, Guangqiang Chen, Hongya Wu, Hongya Wu, Pengfei Xing, Pengfei Xing, Pengfei Xing, Liyuan Zhang, Liyuan Zhang, Liyuan Zhang
Published 2022-07-01
Article